Bioimpedance Analysis for Hemodialysis
Target Weight Guided by Bioimpedance Analysis in Hemodialysis Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
The goal of this clinical trial is to learn if bioimpedance-guided fluid management can help decrease hemodialysis complications. The main questions it aims to answer are: Does bioimpedance-guided fluid management decrease major cardiovascular events? Does bioimpedance-guided fluid management decrease other hemodialysis complications? Participants will: Take bioimpedance analysis once per month Adjust dry weight according to the analysis as possible in active group Blind the analysis results to the doctor and the patient in the control group
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2024
CompletedFirst Posted
Study publicly available on registry
August 27, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 11, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 11, 2026
CompletedFebruary 13, 2026
February 1, 2026
1.4 years
August 21, 2024
February 11, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Major adverse cardiovascular events
A composite of myocardial infarction, stroke and all-cause mortality
From first bioimpedance analysis done to 1 year later
Secondary Outcomes (5)
The number of hemodialysis sessions with intradialytic hypotension
From first bioimpedance analysis done to 1 year later
The number of hemodialysis sessions with intradialytic cramps or postdialytic cramps
From first bioimpedance analysis done to 1 year later
The number of hemodialysis sessions with pitting edema
From first bioimpedance analysis done to 1 year later
The number of hemodialysis sessions with lung edema
From first bioimpedance analysis done to 1 year later
The number of hemodialysis sessions with non-function of arteriovenous shunt
From first bioimpedance analysis done to 1 year later
Study Arms (2)
Bioimpedance
EXPERIMENTALUse overhydration value obtained by bioimpedance analysis to guide fluid management; the measurements will be obtained once per month
Control
PLACEBO COMPARATORBioimpedance analysis done, but the results will be masked to the participants, care providers and outcome evaluators
Interventions
Experimental: use overhydration value obtained by bioimpedance analysis to guide fluid management; the measurements will be obtained once per month
Placebo Comparator: the measurements will also be obtained once per month, but not revealed to the participants and the care providers
Eligibility Criteria
You may qualify if:
- Has received hemodialysis \>= 3 months
- Has at least 1 pair of intact same-side upper extremity and lower extremity
You may not qualify if:
- Pregnant
- With a cardiac pacemaker
- With metallic implants that may interfere with measurements (cardiac stents acceptable)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cishan Hospital, MOHW, Taiwan
Kaohsiung City, 842, Taiwan
Related Publications (6)
Liu L, Sun Y, Chen Y, Xu J, Yuan P, Shen Y, Lin S, Sun W, Ma Y, Ren J, Liu W, Lei J, Zuo L. The effect of BCM guided dry weight assessment on short-term survival in Chinese hemodialysis patients : Primary results of a randomized trial - BOdy COmposition MOnitor (BOCOMO) study. BMC Nephrol. 2020 Apr 15;21(1):135. doi: 10.1186/s12882-020-01793-x.
PMID: 32295531RESULTOnofriescu M, Mardare NG, Segall L, Voroneanu L, Cusai C, Hogas S, Ardeleanu S, Nistor I, Prisada OV, Sascau R, Covic A. Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: effects on blood pressure, hydration status, and arterial stiffness. Int Urol Nephrol. 2012 Apr;44(2):583-91. doi: 10.1007/s11255-011-0022-y. Epub 2011 Jun 19.
PMID: 21688195RESULTHur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, Kayikcioglu M, Demirci MS, Ozkahya M, Duman S, Ok E. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013 Jun;61(6):957-65. doi: 10.1053/j.ajkd.2012.12.017. Epub 2013 Feb 15.
PMID: 23415416RESULTOnofriescu M, Hogas S, Voroneanu L, Apetrii M, Nistor I, Kanbay M, Covic AC. Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis. 2014 Jul;64(1):111-8. doi: 10.1053/j.ajkd.2014.01.420. Epub 2014 Feb 28.
PMID: 24583055RESULTHuan-Sheng C, Yeong-Chang C, Ming-Hsing H, Fan-Lieh T, Chu-Cheng L, Tsai-Kun W, Hung-Ping C, Sze-Hung H, Hsien-Chang C, Chia-Chen L, Chun-Cheng H, Chun-Ting C, Hung-Hsiang L, Chun-Ju L, Paik-Seong L. Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes. Int Urol Nephrol. 2016 Nov;48(11):1897-1909. doi: 10.1007/s11255-016-1415-8. Epub 2016 Sep 12.
PMID: 27620902RESULTPatel HV, Annigeri RA, Kowdle PC, Rao BS, Seshadri R, Balasubramanian S, Vadamalai V. Bioimpedance Spectroscopy-Guided Ultrafiltration Normalizes Hydration and Reduces Intradialytic Adverse Events in Hemodialysis Patients. Indian J Nephrol. 2019 Jan-Feb;29(1):1-7. doi: 10.4103/ijn.IJN_150_18.
PMID: 30814786RESULT
Study Officials
- STUDY CHAIR
Han-Ming Kuo, Master
Cishan Hospital, MOHW, Taiwan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Division of Nephrology
Study Record Dates
First Submitted
August 21, 2024
First Posted
August 27, 2024
Study Start
September 1, 2024
Primary Completion
February 11, 2026
Study Completion
February 11, 2026
Last Updated
February 13, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- one year after the research published
- Access Criteria
- The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.